Literature DB >> 27155164

Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.

Rachel Raynes1, Laura C D Pomatto1, Kelvin J A Davies2.   

Abstract

The proteasome is a ubiquitous and highly plastic multi-subunit protease with multi-catalytic activity that is conserved in all eukaryotes. The most widely known function of the proteasome is protein degradation through the 26S ubiquitin-proteasome system, responsible for the vast majority of protein degradation during homeostasis. However, the proteasome also plays an important role in adaptive immune responses and adaptation to oxidative stress. The unbound 20S proteasome, the core common to all proteasome conformations, is the main protease responsible for degrading oxidized proteins. During periods of acute stress, the 19S regulatory cap of the 26S proteasome disassociates from the proteolytic core, allowing for immediate ATP/ubiquitin-independent protein degradation by the 20S proteasome. Despite the abundance of unbound 20S proteasome compared to other proteasomal conformations, many publications fail to distinguish between the two proteolytic systems and often regard the 26S proteasome as the dominant protease. Further confounding the issue are the differential roles these two proteolytic systems have in adaptation and aging. In this review, we will summarize the increasing evidence that the 20S core proteasome constitutes the major conformation of the proteasome system and that it is far from a latent protease requiring activation by binding regulators.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptation; Immunoproteasome; Nrf2; Oxidative Stress; Proteasome; Proteolysis

Mesh:

Substances:

Year:  2016        PMID: 27155164      PMCID: PMC4967006          DOI: 10.1016/j.mam.2016.05.001

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  164 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation.

Authors:  Niki Chondrogianni; Fiona L L Stratford; Ioannis P Trougakos; Bertrand Friguet; A Jennifer Rivett; Efstathios S Gonos
Journal:  J Biol Chem       Date:  2003-05-07       Impact factor: 5.157

3.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

4.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

Authors:  Eric Reits; Joost Neijssen; Carla Herberts; Willemien Benckhuijsen; Lennert Janssen; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  The base of the proteasome regulatory particle exhibits chaperone-like activity.

Authors:  B C Braun; M Glickman; R Kraft; B Dahlmann; P M Kloetzel; D Finley; M Schmidt
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

Review 6.  Protein modification by oxidants and the role of proteolytic enzymes.

Authors:  K J Davies
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

7.  FOXO/4E-BP signaling in Drosophila muscles regulates organism-wide proteostasis during aging.

Authors:  Fabio Demontis; Norbert Perrimon
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

Review 8.  The proteasome activator 11 S REG (PA28) and class I antigen presentation.

Authors:  M Rechsteiner; C Realini; V Ustrell
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

9.  A conserved role for the 20S proteasome and Nrf2 transcription factor in oxidative stress adaptation in mammals, Caenorhabditis elegans and Drosophila melanogaster.

Authors:  Andrew M Pickering; Trisha A Staab; John Tower; Derek Sieburth; Kelvin J A Davies
Journal:  J Exp Biol       Date:  2012-10-04       Impact factor: 3.312

10.  Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability.

Authors:  Jennifer Blickwedehl; Manjula Agarwal; Changhyun Seong; Raj K Pandita; Thomas Melendy; Patrick Sung; Tej K Pandita; Naveen Bangia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

View more
  64 in total

1.  Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.

Authors:  Corey L Jones; Evert Njomen; Benita Sjögren; Thomas S Dexheimer; Jetze J Tepe
Journal:  ACS Chem Biol       Date:  2017-08-01       Impact factor: 5.100

2.  Measuring redox effects on the activities of intracellular proteases such as the 20S Proteasome and the Immuno-Proteasome with fluorogenic peptides.

Authors:  Vicent Bonet-Costa; Patrick Y Sun; Kelvin J A Davies
Journal:  Free Radic Biol Med       Date:  2019-07-25       Impact factor: 7.376

3.  Sex-specific stress tolerance, proteolysis, and lifespan in the invertebrate Tigriopus californicus.

Authors:  Helen B Foley; Patrick Y Sun; Rocio Ramirez; Brandon K So; Yaamini R Venkataraman; Emily N Nixon; Kelvin J A Davies; Suzanne Edmands
Journal:  Exp Gerontol       Date:  2019-02-07       Impact factor: 4.032

4.  Regulation of cytochrome P450 enzyme activity and expression by nitric oxide in the context of inflammatory disease.

Authors:  Edward T Morgan; Cene Skubic; Choon-Myung Lee; Kaja Blagotinšek Cokan; Damjana Rozman
Journal:  Drug Metab Rev       Date:  2020-09-08       Impact factor: 4.518

5.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

6.  The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S.

Authors:  Diego Sbardella; Grazia R Tundo; Andrea Coletta; Julien Marcoux; Efthymia Ioanna Koufogeorgou; Chiara Ciaccio; Anna M Santoro; Danilo Milardi; Giuseppe Grasso; Paola Cozza; Marie-Pierre Bousquet-Dubouch; Stefano Marini; Massimo Coletta
Journal:  Cell Mol Life Sci       Date:  2018-03-28       Impact factor: 9.261

7.  Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands.

Authors:  Jiajie Wei; Damien Zanker; Anthony R Di Carluccio; Margery G Smelkinson; Kazuyo Takeda; Mina O Seedhom; Devin Dersh; James S Gibbs; Ning Yang; Ajit Jadhav; Weisan Chen; Jonathan W Yewdell
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 8.  Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2016-11-10       Impact factor: 4.013

Review 9.  Does Bach1 & c-Myc dependent redox dysregulation of Nrf2 & adaptive homeostasis decrease cancer risk in ageing?

Authors:  Kelvin J A Davies; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2019-01-26       Impact factor: 7.376

Review 10.  Proteasome Biology: Chemistry and Bioengineering Insights.

Authors:  Lucia Račková; Erika Csekes
Journal:  Polymers (Basel)       Date:  2020-12-04       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.